The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: a randomized clinical trial.
Standard
The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: a randomized clinical trial. / Menter, Alan; Augustin, Matthias; Signorovitch, James; Yu, Andrew P; Wu, Eric Q; Gupta, Shiraz R; Bao, Yanjun; Mulani, Parvez.
In: J AM ACAD DERMATOL, Vol. 62, No. 5, 5, 2010, p. 812-818.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: a randomized clinical trial.
AU - Menter, Alan
AU - Augustin, Matthias
AU - Signorovitch, James
AU - Yu, Andrew P
AU - Wu, Eric Q
AU - Gupta, Shiraz R
AU - Bao, Yanjun
AU - Mulani, Parvez
PY - 2010
Y1 - 2010
N2 - Psoriasis is associated with health-related quality-of-life impairment and depression.
AB - Psoriasis is associated with health-related quality-of-life impairment and depression.
M3 - SCORING: Zeitschriftenaufsatz
VL - 62
SP - 812
EP - 818
JO - J AM ACAD DERMATOL
JF - J AM ACAD DERMATOL
SN - 0190-9622
IS - 5
M1 - 5
ER -